febuxostat has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honorat, JA; Kinoshita, M; Koda, T; Kumanogoh, A; Mochizuki, H; Nakatsuji, Y; Namba, A; Okuno, T; Sakaguchi, M; Sakoda, S; Sanda, E; Sasaki, T; Shimizu, M; Shirakura, T; Sumi-Akamaru, H; Takata, K; Tamura, M; Yamashita, K | 1 |
| Fujimura, H; Honorat, JA; Kinoshita, M; Koda, T; Mochizuki, H; Nakatsuji, Y; Okuno, T; Sakoda, S; Shirakura, T; Tada, S; Takata, K | 1 |
2 other study(ies) available for febuxostat and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferase, Mitochondrial; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Energy Metabolism; Febuxostat; Humans; Mice; Mitochondria; Neurons; Oligonucleotide Array Sequence Analysis; Rotenone; Xanthine Oxidase | 2017 |
Xanthine oxidase mediates axonal and myelin loss in a murine model of multiple sclerosis.
Topics: Animals; Axons; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Febuxostat; Female; Mice; Multiple Sclerosis; Myelin Sheath; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2013 |